Application of continuous blood purification combined with hemoperfusion in the treatment of hemolytic-uremic syndrome in children

ZHU Ying; DONG Yang; XU Da-Liang; JIANG Jia-Yun

doi:10.7499/j.issn.1008-8830.2013.01.014

PDF(905 KB)

Chinese Journal of Contemporary Pediatrics ›› 2013, Vol. 15 ›› Issue (1) : 53-55. DOI: 10.7499/j.issn.1008-8830.2013.01.014

CLINICAL RESEARCH

Application of continuous blood purification combined with hemoperfusion in the treatment of hemolytic-uremic syndrome in children

ZHU Ying, DONG Yang, XU Da-Liang, JIANG Jia-Yun

Author information +

History +

Abstract

OBJECTIVE: To observe the therapeutic effect of continuous blood purification (CBP) combined with hemoperfusion (HP) in children with hemolytic-uremic syndrome (HUS) and to investigate its possible mechanism. METHODS: Eight children with HUS received CBP combined with HP on the basis of internal medicine treatment in the acute stage. Before and after treatment, serum levels of interleukin-6 (IL-6), IL-8 and tumor necrosis factor-α (TNF-α) were measured by chemiluminescence method, and levels of blood urea nitrogen (BUN), serum creatinine (SCr), alanine aminotransferase (ALT), aspartate aminotransferase (AST), creatine kinase (CK), creatine kinase MB (CKMB), hemoglobin (Hb), platelet (PLT) and C-reactive protein (CRP) were measured. Eight healthy children undergoing physical examination were used as controls. RESULTS: The 8 children with HUS all survived after CBP combined with HP and showed improved conditions. They had increased Hb and PLT levels and decreased serum levels of IL-6, IL-8, TNF-α, BUN, SCr, ALT, CK and CRP after treatment (P<0.05). CONCLUSIONS: CBP combined with HP can quickly remove pathogenic factors, continually eliminate inflammatory mediators and toxins, and reverse multiple organ dysfunction, and is one of effective methods for treating HUS in children.

Key words

Hemolytic-uremic syndrome / Continuous blood purification / Hemoperfusion / Child

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

ZHU Ying, DONG Yang, XU Da-Liang, JIANG Jia-Yun. Application of continuous blood purification combined with hemoperfusion in the treatment of hemolytic-uremic syndrome in children[J]. Chinese Journal of Contemporary Pediatrics. 2013, 15(1): 53-55 https://doi.org/10.7499/j.issn.1008-8830.2013.01.014

References

［1］赵季琳.溶血尿毒综合征［M］//胡亚美,江载芳. 诸福堂实用儿科学(下册). 第7版. 北京:人民卫生出版社,2002:1659-1662.

［2］Santiago MJ, López-Herce J, Urbano J, Solana MJ, del Castillo J, Ballestero Y, et al.Clinical course and mortality risk factors in critically ill children requiring continuous renal replacement therapy［J］. Intensive Care Med, 2010, 36(5): 843-849.

［3］Psotka MA, Obata F, Kolling GL, Gross LK, Saleem MA, Satchell SC, et al. Shiga toxin 2 targets the murine renal collecting duct epithelium［J］. Infect Immun, 2009, 77(3): 959-969.

［4］Zoja C, Buelli S, Morigi M. Shiga toxin-associated hemolytic uremic syndrome: pathophysiology of endothelial dysfunction［J］. Pediatr Nephrol, 2010, 25(11): 2231-2240.

［5］Stahl AL, Sartz L, Karpman D.Complement activation on platelet-leukocyte complexes and microparticles in enterohemorrhagic Escherichia coli-induced hemolytid uremic syndrome［J］. Blood, 2011, 117(20): 5503-5513.

［6］George JN, Terrell DR, Swisher KK, Vesely SK.Lessons learned from the Oklahoma thrombotic thrombocytopenic purpura-hemolytic uremic syndrome registry［J］.J Clin Apher, 2008, 23(4): 129-137.

［7］Fang CJ, Richards A, Liszewski MK, Kavanagh D, Atkinson JP.Advances in understanding of pathogenesis of aHUS and HELLP［J］. Br J Haematol, 2008, 143(3): 336-348.

［8］Provaznikova D, Rittich S, Malina M, Seeman T, Marinov I, Riedl M, et al. Manifestation of atypical hemolytic uremic syndrome caused by novel mutations in MCP［J］. Pediatr Nephrol, 2012, 27(1): 73-81.

［9］Johnson S, Waters A.Is complements a culprit in infection-induced forms of haemolytic uraemic syndrome?［J］. Immunobiology, 2011, 26. ［Epub ahead of print］.

［10］王质刚 .血液净化新概念: 血液净化理论与技术的新进展［J］.中国血液净化, 2008,7(2): 59-60.

［11］Chen ZH, Liu ZH, Yu C, Ji DX, Li LS.Endothelial dysfunction in patients with severe acute pancreatitis:improved by continuous blood purification therapy［J］.Int J Artif organs, 2007, 30(5): 393-400.

［12］Tsuchida K, Yoshimura R, Nakatani T, Takemoto Y. Blood purification for critical illness: cytokines adsorption therapy［J］. Ther Apher Dial, 2006, 10(1): 25-31.

［13］朱颖,董扬,徐达良,江家云,徐媛.连续性血液净化在儿童危重症中的应用［J］. 中国当代儿科杂志,2012,14(2):147-149.